Pure Global

“Elixir” DESyne X2 Novolimus Eluting Coronary Stent System - Taiwan Registration 1a89a125d7449668a1c14783d5884c03

Access comprehensive regulatory information for “Elixir” DESyne X2 Novolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 1a89a125d7449668a1c14783d5884c03 and manufactured by Elixir Medical Corporation;;Acon Regulatory Consultancy Services Ltd. The authorized representative in Taiwan is CLOVERS BIOTECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
1a89a125d7449668a1c14783d5884c03
Registration Details
Taiwan FDA Registration: 1a89a125d7449668a1c14783d5884c03
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Elixir” DESyne X2 Novolimus Eluting Coronary Stent System
TW: “依莉瑟”迪瑟第二代冠狀動脈塗藥支架系統
Risk Class 3
MD

Registration Details

1a89a125d7449668a1c14783d5884c03

Ministry of Health Medical Device Import No. 031833

DHA05603183300

Company Information

Product Details

For details, it is Chinese approved copy of the imitation order

E Cardiovascular devices

E0001 Cardiovascular stents

Imported from abroad; Contract manufacturing

Dates and Status

Oct 10, 2018

Oct 10, 2028